We have a wheelchair accessible entrance and washroom facilities. NewLab Clinical Research has been providing the highest quality clinical trials for advanced therapeutics since 1997. The company was founded by Dr. Wayne Gulliver, a world leader in dermatology and genetics research in psoriasis. The Drug Development business unit was established to commercialize therapeutic products using the gene
tic advantages of a founder population. NewLab has two novel therapeutics in development – next generation Peptide-T drugs for a multitude of auto-immune diseases and drugs targeting HLA Cw6, a part of the human genetic sequence thought to cause the chronic disease psoriasis. The Advisory Services division is responsible for the identification and evaluation of new business opportunities and for the implementation of qualified opportunities through NewLab or through third party collaborations.
